A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Business description not available.
| Metric | TTM | FY2025 | FY2024 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Net Income | -21M | -21M | -19M |
| EPS | $0.00 | $0.00 | $0.00 |
| Free Cash Flow | -14M | -14M | -11M |
| ROIC | -61.7% | -57.5% | -37.0% |
| Gross Margin | - | - | - |
| Debt/Equity | 0.00 | 0.03 | 0.01 |
| Dividends/Share | $0.00 | $0.00 | $0.00 |
| Operating Income | -22M | -22M | -20M |
| Operating Margin | 0.0% | - | - |
| ROE | -27.9% | -27.9% | -21.1% |
| Shares Outstanding | 0M | 0M | 0M |
| Metric | 2024 | 2025 | TTM |
|---|---|---|---|
| Income Statement | |||
| Revenue | 0 | 0 | 0 |
| Gross Margin | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A |
| EBIT | -20M | -22M | -22M |
| Op. Margin | N/A | N/A | 0.0% |
| Net Income | -19M | -21M | -21M |
| Net Margin | N/A | N/A | 0.0% |
| Non-Recurring | 0 | 0 | 0 |
| Returns on Capital | |||
| ROIC | -37.0% | -57.5% | -61.7% |
| ROE | -21.1% | -27.9% | -27.9% |
| ROA | -19.2% | -24.8% | -24.8% |
| Cash Flow | |||
| Op. Cash Flow | -9.1M | -11M | -11M |
| Free Cash Flow | -11M | -14M | -14M |
| Owner Earnings | -21M | -23M | -23M |
| CapEx | 2.4M | 2.6M | 2.6M |
| Maint. CapEx | 8.8M | 9.4M | 9.4M |
| Growth CapEx | 0 | 0 | 0 |
| D&A | 8.8M | 9.4M | 9.4M |
| CapEx/OCF | N/A | N/A | 0.0% |
| Capital Allocation | |||
| Dividends Paid | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | 3.2M | 1.9M | 1.9M |
| Debt Repayment | 0 | 0 | 0 |
| Balance Sheet | |||
| Net Debt | -46M | -44M | -47M |
| Cash & Equiv. | 47M | 47M | 47M |
| Long-Term Debt | N/A | N/A | N/A |
| Debt/Equity | 0.01 | 0.03 | 0.00 |
| Interest Coverage | -23.3 | -15.1 | -15.1 |
| Equity | 90M | 75M | 75M |
| Total Assets | 98M | 84M | 84M |
| Total Liabilities | 8.6M | 9.5M | 9.5M |
| Intangibles | 14M | 11M | 11M |
| Retained Earnings | -65M | -87M | -87M |
| Working Capital | 66M | 55M | 55M |
| Current Assets | 74M | 62M | 62M |
| Current Liabilities | 7.5M | 7.0M | 7.0M |
| Per Share Data | |||
| EPS | 0.00 | 0.00 | 0.00 |
| Owner EPS | N/A | N/A | N/A |
| Book Value | 0.00 | 0.00 | 0.00 |
| Cash Flow/Share | 0.00 | 0.00 | 0.00 |
| Dividends/Share | 0.00 | 0.00 | 0.00 |
| Shares Out. | 0.0M | 0.0M | 0.0M |
| Valuation | |||
| P/E Ratio | N/A | N/A | N/A |
| P/FCF | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A |
| FCF Yield | N/A | N/A | N/A |
| Market Cap | 0 | 0 | 0 |
| Avg. Price | 2.35 | 2.91 | 1.29 |
| Year-End Price | 2.85 | 2.46 | 1.29 |
Nightingale Health Oyj B passes 0 of 9 quality checks, indicating weak fundamentals.
Nightingale Health Oyj B (HEALTH-HE) has a 5-year average return on invested capital (ROIC) of -47.2%. This is below average and may indicate limited pricing power.
Nightingale Health Oyj B (HEALTH-HE) does not currently pay a regular dividend.
Nightingale Health Oyj B (HEALTH-HE) generated $-14 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Nightingale Health Oyj B (HEALTH-HE) has a debt-to-equity ratio of 0.03. This indicates a conservatively financed balance sheet.
Nightingale Health Oyj B (HEALTH-HE) has a return on equity (ROE) of -27.9%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 2 years of financial data for Nightingale Health Oyj B (HEALTH-HE), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.